Adipotide Nasal Spray

Product Details: Adipotide Nasal Spray

Adipotide is an experimental peptide-based compound. It is investigated in laboratory settings for its interaction with adipose tissue and vascular targeting mechanisms. It is classified as a prohibiting-targeting peptide. It is also under study in preclinical and animal models. This is done to understand its effects on cellular and vascular systems associated with adipose tissue.

It was originally developed within experimental oncology research. Adipotide has been examined for its interaction with blood vessel structures supplying specific cell populations. In research environments, it is utilized to study peptide-mediated targeting mechanisms and apoptosis-related signaling pathways.

Researchers investigate Adipotide in controlled models to explore:

• vascular targeting mechanisms in adipose tissue systems
• prohibitin-mediated binding interactions in experimental models
• apoptosis signaling pathways in targeted cellular environments
• peptide-induced changes in tissue-specific vascular structures

Mechanism of Action

Adipotide Nasal Spray is investigated for its interaction with prohibitin. It is a protein expressed on the surface of blood vessels associated with adipose tissue in experimental models. Upon binding to this target, the compound is studied for its ability to initiate cellular signaling processes. The ones that are associated with programmed cell death (apoptosis).

This interaction may affect vascular integrity in targeted tissues. This allows researchers to examine how peptide-based compounds affect blood vessel structure and function in controlled laboratory environments. These mechanisms are analyzed using biochemical assays and preclinical research systems.

Properties of Adipotide:

• Molecular Formula: C111H204N36O28S2
• Molecular Weight: 2555.22 g/mol
• CAS Number: 137525-51-0
• IUPAC Name: Hexanediamide
• Synonyms: Prohibitin-targeting peptide 1, FTPP (Fat Targeted Proapoptotic Peptide)

Research Applications/Benefits of Adipotide Nasal Spray

Adipose Tissue Targeting Studies:

Researchers are investigating Adipotide for its role in targeting vascular structures associated with adipose tissue in preclinical models. Experimental findings suggest peptide binding interactions may influence tissue-specific vascular dynamics.

Apoptosis Pathway Analysis:

Adipotide is studied for its involvement in apoptosis-related signaling pathways in laboratory systems. These investigations focus on programmed cell death mechanisms and peptide-induced cellular responses.

Vascular Biology Research:

This compound is utilized in experimental models to examine blood vessel structure and function in targeted tissues. Studies explore how peptide interactions influence vascular integrity and cellular environments.

Peptide-Receptor Interaction Studies:

Adipotide is also investigated in biochemical assays to evaluate peptide binding specificity, receptor interactions, and downstream molecular signaling processes.

Why Choose BehemothLabz to Buy Adipotide Nasal Spray?

Choose Behemoth Labz for high-quality research compounds developed to meet strict laboratory standards. Our Adipotide Nasal Spray is produced under controlled conditions and undergoes third-party testing to verify purity, composition, and consistency.

We provide reliable sourcing and secure packaging of products including adipotide nasal spray 6 and adipotide for sale to support laboratory research applications. Our commitment to quality and transparency ensures that researchers receive dependable materials for experimental use.

Disclaimer: This information is for educational purposes. We do not allow the human consumption of our products. All our products are sold for laboratory and research experiments. Also note that Adipotide Nasal Spray is not the same as the AOD 9604 nasal spray.

ATTENTION: All BehemothLabz products are strictly for LABORATORY AND RESEARCH PURPOSES ONLY. They are not to be used for any human or veterinary purposes.

References:

1. Kolonin, M. G., Saha, P. K., Chan, L., Pasqualini, R., & Arap, W. (2004). Reversal of obesity by targeted ablation of adipose tissue. Nature Medicine, 10(6), 625–632. https://pubmed.ncbi.nlm.nih.gov/15133506/